Quantcast

Latest aortic aneurysm Stories

2010-12-20 08:00:00

IRVINE, Calif., Dec. 20, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that Guido Neels, Managing Director at Essex Woodlands Health Ventures, has joined the Endologix Board of Directors. Essex Woodlands was the majority shareholder of Nellix Inc, which was acquired by Endologix in an all stock transaction on December 13, 2010. In conjunction with the acquisition, Essex Woodlands made a $15...

2010-12-13 08:00:00

IRVINE, Calif., Dec. 13, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has completed the acquisition of Nellix, Inc. Nellix has developed a revolutionary new device for the treatment of Abdominal Aortic Aneurysms (AAAs) that is expected to address the limitations of existing endovascular aneurysm repair (EVAR) devices and expand the global AAA market. Endologix announced its agreement...

2010-11-29 11:46:00

IRVINE, Calif., Nov. 29, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences. The first presentation will be at the 22nd Annual Piper Jaffray Health Care Conference in New York. Event: 22nd Annual Piper Jaffray Health Care Conference Date: Tuesday, November...

2010-11-18 16:42:17

TAAD causes thousands of deaths in the United States each year. Although timely surgical repair of aneurysms can prevent death, thoracic aneurysms are often asymptomatic until dissection (tearing of the vessel wall), and there are few recognized risk factors that can be used for screening. "Prospective identification of patients at risk for TAAD using a genetic strategy will be critical to prevent sudden deaths from this treatable disease," explains senior study author Dr. John W. Belmont...

2010-11-18 16:26:58

Researchers find fifth gene defect, 47 DNA regions linked to disease Discovery of a fifth gene defect and the identification of 47 DNA regions linked to thoracic aortic disease are the subject of studies released this month involving researchers at The University of Texas Health Science Center at Houston (UTHealth). In both studies, the investigators have identified alterations in the genetic material or DNA that affect the ability of smooth muscle cells, which line the aorta and other blood...

2010-11-12 08:00:00

IRVINE, Calif., Nov. 12, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that a podium presentation on the Company's Ventana(TM) fenestrated stent graft will be given at the VEITHsymposium 2010 in New York by Daniel G. Clair, MD, Chairman, Cleveland Clinic Department of Vascular Surgery, Cleveland, OH, and co-chair of the VEITHsymposium. Dr. Clair participated in the first implant of the Ventana...

2010-11-02 08:15:00

IRVINE, Calif., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today the first clinical implant of the Company's Ventana(TM) fenestrated stent graft at Auckland City Hospital in Auckland, New Zealand. The procedure was performed by Andrew Holden, MD (Associate Professor and Director of Interventional Radiology) and Andrew, Hill, MD (Associate Professor of Surgery). Attending the procedure...

2010-10-27 15:01:00

IRVINE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has signed a definitive agreement to acquire Nellix, Inc, a privately-held medical device company that has developed a revolutionary endograft for the treatment of Abdominal Aortic Aneurysms (AAAs). Under the terms of the agreement, Endologix will acquire Nellix for $15 million in stock at closing, plus additional...

2010-10-25 08:00:00

IRVINE, Calif., Oct. 25 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the Oppenheimer 21st Annual Healthcare Conference in New York, NY. Event: Oppenheimer's 21st Annual Healthcare Conference Date: Tuesday, November 2, 2010 Time: 12:00 p.m. ET An audio Web cast of the...

2010-10-21 00:00:41

M2S, Inc., a leading provider of medical image and clinical data analysis services, has released version 1.7 of its Clinical Data Pathways vascular quality improvement database. This release provides new procedure forms and fields, as well as user interface enhancements in response to customer feedback. West Lebanon, NH (Vocus) October 20, 2010 M2S, Inc., a leading provider of medical image and clinical data analysis services, has released version 1.7 of its Clinical Data Pathways vascular...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related